ACM
BCYC

Altium Capital Management’s Bicycle Therapeutics BCYC Stock Holding History

Altium Capital Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,352
Closed -$565K – 32
2024
Q4 		$565K Sell
40,352
-44,648
-53% -$957K 0.16% 56
2024
Q3 		$1.92M Buy
+85,000
New +$1.96M 0.57% 43
2022
Q2 		– Sell
-120,000
Closed -$5.27M – 128
2022
Q1 		$5.27M Sell
120,000
-52,000
-30% -$2.43M 1.76% 18
2021
Q4 		$10.5M Buy
172,000
+80,000
+87% +$4.41M 2.89% 4
2021
Q3 		$3.83M Buy
+92,000
New +$3.22M 1% 42

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Altium Capital Management's BCYC Position: Q1 2025 in Review

Altium Capital Management sold out of Bicycle Therapeutics (BCYC) in Q1 2025, closing a stake of 40,352 shares — an estimated $565K sold.

Altium Capital Management first reported a position in BCYC in Q3 2021 and held it in 5 quarters. The position peaked at $10.5M in Q4 2021. 95 funds tracked by Wall St. Rank hold BCYC as of Q1 2025.

  • Altium Capital Management reported no remaining Bicycle Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Altium Capital Management sold 40,352 Bicycle Therapeutics shares in Q1 2025, an estimated $565K.
  • Altium Capital Management first reported a position in Bicycle Therapeutics in Q3 2021 and held it in 5 quarters.
  • Altium Capital Management's Bicycle Therapeutics position peaked at $10.5M in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2025.

Based on Altium Capital Management's 13F filing for Q1 2025, filed 9 May 2025.